Kei Sakamoto
keisakamoto.bsky.social
Kei Sakamoto
@keisakamoto.bsky.social
Professor Univ. of Copenhagen, Vice Director Novo Nordisk Foundation Center for Basic Metabolic Research, Metabolic Signaling, glucose metabolism, AMPK
Reposted by Kei Sakamoto
The structure of BAY-3827 with wild-type AMPK α2 kinase domain by @zeqiraj.bsky.social & postdoc Mohd. Syed Ayengar helped determine the mechanism of action of this compound and the limitations for its use, addressing a long-standing challenge in the field: the absence of specific AMPK inhibitors.
September 9, 2025 at 3:17 PM
Many congrats Elton. Hope our manuscript is the next success!!
March 18, 2025 at 3:52 PM
Hope you just us next time:)
March 6, 2025 at 12:49 PM